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The γ-index test has been commonly adopted to quantify the degree of 
agreement between a reference dose distribution and an evaluation dose 15 
distribution. Monte Carlo (MC) simulation has been widely used for the 
radiotherapy dose calculation for both clinical and research purposes. The goal 
of this work is to investigate both theoretically and experimentally the impact of 
the MC statistical fluctuation on the γ-index test when the fluctuation exists in 
the reference, the evaluation, or both dose distributions. To the first order 20 
approximation, we theoretically demonstrated in a simplified model that the 
statistical fluctuation tends to overestimate γ-index values when existing in the 
reference dose distribution and underestimate γ-index values when existing in 
the evaluation dose distribution given the original γ-index is relatively large for 
the statistical fluctuation. Our numerical experiments using realistic clinical 25 
photon radiation therapy cases have shown that 1) when performing a γ-index 
test between an MC reference dose and a non-MC evaluation dose, the average 
γ-index is overestimated and the gamma passing rate decreases with the increase 
of the statistical noise level in the reference dose; 2) when performing a γ-index 
test between a non-MC reference dose and an MC evaluation dose, the average 30 
γ-index is underestimated when they are within the clinically relevant range and 
the gamma passing rate increases with the increase of the statistical noise level 
in the evaluation dose; 3) when performing a γ-index test between an MC 
reference dose and an MC evaluation dose, the gamma passing rate is 
overestimated due to the statistical noise in the evaluation dose and 35 
underestimated due to the statistical noise in the reference dose. We conclude 
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that the γ-index test should be used with caution when comparing dose 
distributions computed with Monte Carlo simulation. 
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1. Introduction 
 
Dose distribution comparison is a frequently performed task in radiotherapy, where the 
degree of agreement between an evaluation dose distribution and a reference one is 
established using some quantitative metrics. For example, in a typical patient-specific 5 
quality assurance procedure for a radiotherapy treatment, a treatment plan is delivered to 
a phantom before the actual treatment, and the measured dose distribution is compared 
with the calculated dose distribution by the treatment planning system. Over the years, 
several dose comparison methods have been developed, including the quantitative dose 
difference test, the distance-to-agreement (DTA) test (Vandyk et al., 1993; Harms et al., 10 
1998), the composite analysis for both dose difference and DTA (Shiu et al., 1992; 
Cheng et al., 1996; Harms et al., 1998), the γ-index test (Low et al., 1998; Depuydt et al., 
2002; Low and Dempsey, 2003; Bakai et al., 2003; Stock et al., 2005; Wendling et al., 
2007; Ju et al., 2008; Chen et al., 2009; Yuan and Chen, 2010; Low, 2010; Gu et al., 
2011b), and the test based on the maximum allowed dose difference (MADD) (Jiang et 15 
al., 2006). Among these, the γ-index test is the one most commonly used. This method 
combines quantifications of dose differences between two dose distributions in both the 
dose domain and the spatial domain. This allows for the toleration of spatial shifts when 
comparing the two dose distributions, which is clinically acceptable, and avoids an 
exaggeration of dose differences in the area of a high dose gradient. Moreover, the γ-20 
index test is quantitatively comprehensible. Based on the user specified criteria, e.g. 3% 
for the dose difference criterion and 3 mm for the DTA criterion (3%-3mm), the user can 
judge how good the agreement is based on the value of the γ-index. The smaller the γ-
index value is, the closer the two dose distributions are. 
 In many contexts, the γ-index test is used to evaluate the agreement between two 25 
dose distributions, where one, or both of them, is calculated by Monte Carlo (MC) 
simulations. For instance, because of the high accuracy of the MC method it is desirable 
to verify the dose distribution calculated by a treatment plan system by comparing it with 
another one independently calculated using an MC method (Calvo et al., 2012). This 
situation is becoming more and more common as MC dose calculations become more 30 
efficient with novel algorithms and hardware developments (Jia et al., 2010; Jia et al., 
2011; Hissoiny et al., 2011; Wang et al., 2011). It is also common, when developing new 
dose calculation algorithms, to consider the MC dose as the golden standard and test the 
accuracy of the new algorithms against it via γ-index tests (Jelen and Alber, 2007; Gu et 
al., 2011a; Hissoiny et al., 2011). 35 
 However, MC is a statistical method and the statistical fluctuation is unavoidable 
in the resulting dose distributions. This fluctuation may have non-negligible impacts on 
the γ-index values and hence lead to biased conclusions from the γ-index test (Low and 
Dempsey, 2003; Low, 2010). This fact is easily understood from the graphical 
interpretations of the γ-index (Ju et al., 2008). Let us consider a simple case where two 40 
1D dose distributions are compared as in Figure 1(a). Suppose we plot the two dose 
distributions,       and      with normalized coordinates      and    , where       and       
are the normalized reference dose distribution and the normalized evaluation dose 
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distribution respectively;    and    are DTA and dose-difference criteria, respectively. 
It has been shown that the γ-index value at a coordinate  , denoted as   , is simply the 
minimum Euclidian distance from the point    to the evaluation dose distribution, which 
is graphically represented by a circle centered at    such that the evaluation dose 
distribution is tangent to it. Figure 1(b) illustrates an example of how the γ-index value 5 
changes due to the MC statistical fluctuations in the evaluation dose. Suppose with 
fluctuations the evaluation dose distribution       becomes   
    , the new γ-index value   
  
could be different from the original one  Similarly, Figure 1(c) illustrates an example 
where the γ-index value is affected by the MC statistical fluctuations in the reference 
dose. Considering these scenarios, a few key questions need to be answered before 10 
comparing two dose distributions where an MC dose is involved: while the γ-index value 
apparently depends on a specific random realization of the dose distributions, what is the 
impact on average? How significant is this impact on, the clinically more important 
quantity, gamma passing rate? Also, since the γ-index value is not symmetric with 
respect to the two distributions (Low and Dempsey, 2003; Low, 2010), we have one more 15 
question: Is the impact different when the statistical fluctuation exists in the reference 
dose, in the evaluation dose, or in both of them?  
 The purpose of this paper is to systematically investigate the impact of the MC 
statistical fluctuation on the γ-index test. Specifically, we will demonstrate in a simplified 
model that, to the first order approximation, statistical fluctuation in the reference dose 20 
tends to overestimate γ-index values, while that in the evaluation dose tends to 
underestimate γ-index values when they are within the clinically relevant range. We also 
demonstrate these effects using one prostate and one head-and-neck (HN) clinical photon 
radiation therapy cases. 
 
Figure 1 (a). Graphical interpretation of the γ-index in one-dimension. (b). An example 
demonstrating how the γ-index value changes due to MC statistical fluctuations in the evaluation 
dose. (c). An example demonstrating how the γ-index value changes due to MC statistical 
fluctuations in the reference dose. 
 25 
2. Methods and Materials 
 
2.1 γ-index test 
  
Let us consider two dose distributions to be compared,    and  . Mathematically, the γ-30 
index at a comparison point             is defined as  
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Here       is the reference dose distribution at position    and       is the evaluation 
dose distribution at position   .    is dose difference criterion and    is the DTA 
criterion. If the γ-index is equal to or less than 1, the dose at the spatial point    is 
considered to pass the test.  
 The graphical interpretation of the γ-index has been established previously (Ju et 5 
al., 2008) and illustrated in Figure 1(a). Specifically, the γ-index is defined as the 
minimum Euclidian distance from the point    to the evaluation dose curve. In practice, 
the evaluation dose is usually defined at discrete spatial locations. To the first order 
approximation, Ju et al assumed a linear interpolation of the dose values between 
neighboring spatial points as shown in Figure 1, and developed a simple and efficient γ-10 
index calculation algorithm. This method is widely used nowadays (i.e. Gu et al., 2011b). 
In this study, we keep this linear interpolation and our analysis in next section is built 
based on this implementation. 
 
2.2. Theoretical analysis of MC statistical fluctuation effects on the γ-index test 15 
 
The γ-index value for a particular random realization of dose distributions is essentially a 
random variable. It is more meaningful to investigate how the γ-index test is affected on 
average, i.e. the average impact over all the random dose realizations. In this section, we 
outline a theoretical calculation in a simplified 1D model for the mean γ-index value 20 
when there exist MC statistical fluctuations in the dose distributions. Theoretical analysis 
based on this simplified model is intended to offer some theoretical insights rather than a 
strict theoretical proof. We then validate our theoretical conclusions for 3D cases using 
real clinical data.  
 25 
2.2.1 MC statistical fluctuations in the reference dose 
 
In Figure 2,         is the line segment of the evaluation dose curve,    is the reference 
point,    is the original γ-index value and   parameterizes the deviation due to the 
statistical fluctuation. In this simplified model, the new γ-index value is always the 30 
minimum Euclidian distance from the point    to the line segment         of the 
evaluation dose curve, not to the other line segment of the evaluation dose curve. Here 
we first introduce the concept of signed-gamma index  , such that its magnitude is the 
radius for a circle centered at the reference point on the reference dose and tangent to the 
evaluation dose curve, but its sign is positive if the center of the circle is below the 35 
evaluation dose curve (e.g. Figure 2(a)) and negative if the center is above the curve (e.g. 
Figure 2(b)). Since the number of particles in the MC simulation is usually very large to 
ensure a small uncertainty level of clinical relevance; and with the large number of 
particles, the dose to a voxel in an MC simulation is commonly considered following a 
Gaussian distribution (Sempau and Bielajew, 2000). In this study, we assume that 40 
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probability density function      is symmetric around zero. Note that            
where   is the angle between    and vertical axis, it is straightforward that 
                 
  
  
, (2) 
For the average gamma index,  
     
  
  
                         
  
    
  
                 
  
  
    
. (3) 
Now, subtracting Equations (2) and (3) leads to  
                       
  
  
    
  (4) 
Since        when   
  
    
, we can conclude that 5 
      . (5) 
 This conclusion is valid for a general symmetric probability density function 
    . It has also been theorized that the statistical fluctuations of the dose distribution in 
an MC calculation, termed as “noise” from here on, follow a Gaussian distribution 
(Sempau and Bielajew, 2000). So in this case, the average gamma index is then specified 
to be 10 
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where    is statistical uncertainty value on the reference point. Then the Equation (6) can 
be rewritten as  
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The derivative of Equation (8) with respect to    is 
  
   
  
 
 
        
   
 
        
  .  (9) 
Since 
  
   
  , and when              we get the same conclusion as Equation (5).   
 The increase of the average γ-index   can be understood as following. When 15 
there is a finite deviation  , there are two scenarios resulting different impacts on the 
average γ-index. First, when   is small for the original γ-index   , i.e.   
  
    
, the 
average of the γ-index pair        and         equals   . Second, when   is large, i.e. 
  
  
    
, the average of the pair         and         is larger than    due to the flipped 
sign in one of them caused by the absolute value operation. It is the latter scenario that 20 
causes the increase of   . Hence when the original γ-index value is relatively large for the 
noise standard deviation, the increase of the average γ-index   will be relatively small 
due to the small contributions from the second scenario. 
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Figures 2 (a) and (b). Illustrations of two different contexts where noise is present in the 
reference dose.  
  
2.2.2 MC statistical fluctuations in the evaluation dose 
 5 
In Figures 3(a) and (b), suppose without noises,         is the line segment of the 
evaluation dose curve. With the MC noises, the line         moves. As in the Section 
2.2.1, similarly we assume in this simplified model, the new γ-index value is only related 
to the line segment         of the evaluation dose curve, not to the other line segment of 
the evaluation dose curve.    ,     are the statistical uncertainties on the dose values at 10 
the points           , the average γ-index value   can be calculated as,  
                             
  
  
  
  
, (10) 
where   ,        parameterizes the deviation of dose values at the two points      and 
    and          is the probability density function. For some noise realizations, the 
signed-gamma index   may change its sign from positive to negative. For instance, in 
Figure 3(a) when both    and    are large negative values. However, the probability of 15 
this situation is relatively small, given that     are small for   . Hence, we first ignore the 
contributions of γ-indices from these situations. The consequence when this contribution 
cannot be ignored will be discussed later. Given this assumption, all   are positive 
regardless of the values of   .  
As for the probability distribution, for the large number of particles simulated in 20 
an MC dose calculation, we assume that                    . When the noises at two 
points      and     are statistically independent, this assumption is apparently valid, as 
the noise distribution at each point is symmetric about zero. In reality, there exist 
correlations of noises between these two points. This correlation is caused by an electron 
track that passes through the two voxels. In one MC simulation, the number of electron 25 
tracks simultaneously passing the two voxels fluctuates about its average, and the 
probability of having more tracks is equal to that of having less tracks. Hence our 
assumption is still valid. Under this assumption, we can rewrite Equation (10) as 
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From Figure 3(c), we further separate the integral domain into four different quadrants, 
  
 
 
                     
 
                        . (12) 
Since the integrals in the domain    and    equal to those in the domain    and    , 
respectively, Equation (12) reduces to 
                      
 
                         . (13) 
Figure 3(a) illustrates the context when    and    are both positive (in domain   ). 
Suppose     
     
  and        are the new evaluation dose lines, such that        and 5 
      
   are of the same length, similarly        and       
  are of the same length, and 
         is represented as     while             is    .     is the original γ-
index     If we set CF     
     
 , we have 
                  .    (14) 
Since                    and                  , combining with Equation 
(14), we can get  10 
                            (15) 
Moreover                    . From the geometric relationship, we also have 
                   and                 . Hence, 
                
              . (16) 
This indicates that 
                                           
≤                        
  (17) 
Similarly, Figure 3(b) illustrates a context where    is negative and    is positive (in 
domain   ).            is represented as     while            is    .     is the original 15 
γ-index   . With a similar derivation, we can generate the same conclusion as Equation 
(17).  
                                           
≤                        
  (18) 
Combine Equation (13), (17) and (18), we then have 
                            
 
        
(19) 
Since                      
 
     , we can conclude that   
       (20) 
 This indicates that the presence of noise will lead to an underestimation of the γ-20 
index value. It is important to note that when the probability for negative signed γ-index 
         is not negligible, i.e. when the noise standard deviation is relatively large for the 
original γ-index value, Equation (20) is no longer valid. The simplest case is when the 
reference dose distribution is the same as the evaluation dose and γ-index values are all 
zero. In this case, the MC noise in the evaluation dose distribution leads to an 25 
overestimation of γ-index values. However, as later shown in our numerical experiments, 
this situation is not clinically relevant because it only happens when the original γ-index 
values are very small and their variation due to the MC noise does not affect the γ-index 
passing rate. 
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Figures 3 (a) and (b). Illustrations of two different contexts where noise is present in the 
evaluation dose. (c). Split of the integration domain for Equation (11). 
 
2.3 Numerical experiments  5 
 
We conducted numerical experiments on two realistic clinical cases for photon radiation 
therapy: a 7-beam IMRT prostate plan and a 2-arc VMAT HN plan. To study the effect 
of using an MC dose as the reference dose or the evaluation dose in γ-index tests, a non-
MC dose distribution and a set of MC dose distributions at various   levels (including 10 
zero   level) are required for each clinical case. For the non-MC dose, we used the dose 
distribution in the patient plan extracted from a commercial treatment planning system 
(Eclipse, Varian Medical Inc., Palo Alto, CA) which was computed using the Analytical 
Anisotropic Algorithm (AAA). The resulting dose from the Eclipse system is at a 
resolution of 2.5×2.5×2.5     and interpolated to the MC dose resolution of 15 
1.953×1.953×2.5   . The AAA algorithm is an analytical algorithm hence there is no 
noise in the dose. To get the set of MC dose distributions, we first extracted the MLC leaf 
sequences of all beam angles from the patient plan. Using different number of particle 
histories in the simulation, the dose distributions of various   level were calculated on the 
patient geometry using a GPU-based MC dose engine (gDPM) (Jia et al., 2011). In this 20 
work we define the term   level as the average   value normalized to the maximum dose 
     within regions of dose values higher than 50% of      (VOI50%). The dose 
distributions with   level of 0.5%, 1%, 1.5%, and 2% were calculated, which are the 
most clinically relevant noise levels for MC dose calculations. An additional dose 
distribution of   level of 0.2% was also computed and used to obtain the MC dose with 25 
zero   level. As such we determined the de-noised dose value      by solving such an 
optimization problem 
                                         
 
 
           (21) 
The first term in the energy function      is a data-fidelity term considering the Poisson 
noise, while the second term is a penalty term to ensure the smoothness of the de-noised 
dose     . Since the energy function is convex, the optimality condition is researched by 30 
solving  
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      . (22) 
This model is solved using a gradient descent method. We would like to point out that the 
beam parameters in the gDPM code were not purposely tuned to match the Eclipse 
results. To analyze the situation when both the evaluation and reference doses are 
generated by the MC method, another set of MC dose distributions at various   levels 
(including zero   level) is desired. For this set of MC doses, we used the same MC dose 5 
engine gDPM, but shifted the isocenter position of all beams by 3 mm to the patient's left, 
posterior, and superior directions, respectively, to simulate the dosimetric effects due to a 
set up error in a clinical situation.  
 To study the impact of the MC noise on the γ-index value, we first needed to 
conduct a base comparison between the non-MC dose and the MC dose with zero   level; 10 
the resulting γ-index values of a selected group of voxels are treated as the base values. 
Then the γ-index results for the same voxels were followed when the non-MC dose is 
compared with the MC doses of increasing   levels. These voxels are selected as the ones 
with more clinical relevance. Since the passing rate within a region of interest (ROI) is 
the most common criteria used to compare two dose distributions, we focused on a range 15 
of γ-index values that contribute to the calculation of the gamma passing rate. We also 
noticed that the behavior of average γ-index variation due to the MC noise is similar for 
close γ-index values. Thus, based on the base comparison, we selected four groups of 
voxels in the reference dose distribution with γ-index values from value 0.6 to 0.8 (0.6, 
0.8), from value 0.8 to 1 (0.8, 1.0), from value 1 to 1.2 (1.0, 1.2), and from value 1.2 to 20 
1.4 (1.2, 1.4). For each group of voxels, we followed the variation of the average γ-index 
value with the increase of the   level in the MC dose distribution. Furthermore, the γ-
index passing rates were also reported for each comparison between the non-MC dose 
and the MC dose. In this study, in addition to VOI50%, we also selected another ROI 
where dose values were higher than 10% of      (VOI10%). 25 
 Since the MC noise is a random variable, for the comparison at each   level, we 
repeated the γ-index test ten times for ten different random realizations of the dose 
distributions to get the mean of the γ-index test results. And during our experiments, all 
dose distribution comparisons were performed using the GPU-based fast γ-index 
algorithm (Gu et al., 2011b). 30 
 
3. Results   
 
3.1 MC reference dose vs Non-MC evaluation doses 
 35 
To study the effect of using an MC dose as the reference dose in γ-index tests, we treated 
the set of MC doses as the reference doses and the non-MC dose as the evaluation dose. 
Figures 4 (A) and (B) show the average γ-index values of voxels whose original γ-indices 
fall within the range of (0.6, 0.8), (0.8, 1.0), (1.0, 1.2) and (1.2, 1.4) as functions of the   
level in the reference dose (         ) for both prostate and HN cases. For Figures 4(A) and 40 
(B), we used the most common clinical γ-index test criterion: 3%-3mm. We can see that 
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the average γ-index value within each group slightly increases with          . Figures 4(C) 
and (D) show the passing rate within VOI50% and VOI10% as function of           for two 
different γ-index test criteria: 3%-3mm and 2%-2mm. It is noted that, although the 
average γ-index value does not change much, the gamma passing rate decreases 
significantly with the increase of the   levels in the reference dose, especially for VOI50% 5 
for these two clinical cases. 
 To better understand the effect of the MC noise on the gamma passing rate, we 
examined the voxels that contribute to the gamma passing rate calculation. We defined 
Type-I voxels as those with γ-index values larger than one in the base comparison when 
the MC   level is zero and γ-index values smaller than or equal to one when the MC   10 
level is 2%. Type-II voxels are those with the opposite situation, i.e., γ-index values 
increasing from below or equal to one to above one when the   level increases from zero 
and 2%. Since the MC noise is a random variable, for a γ-index test with a random 
realization of the MC dose distribution, a particular voxel with the γ-index value around 
one can be either Type-I or Type-II. However, when running the γ-index test for many 15 
random realizations of the MC dose distributions, this voxel will have more chance to be 
Type-II than Type-I when using the MC dose as the reference dose. Table 1 summarizes 
the average percentages of Type-I and Type-II voxels within two ROIs for two 
comparison criteria after running the γ-index test for 10 different random realizations of 
the MC reference dose distributions. It is noted that percentage of Type-II voxels is 20 
higher than that of Type-I. The net effect, Type-II percentage minus the Type-I 
percentage, is equal to the change of the gamma passing rate with the MC dose of 2%   
level, as shown in Figures 4 (C) and (D). 
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Figure 4. Average γ-index and gamma passing rate as functions of   level in the reference dose 
for MC reference doses vs non-MC evaluation dose. (A) and (C): prostate case; (B) and (D): HN 
case. 
 
Table 1. Percentages of Type-I and Type-II voxels within VOI50% and VOI10% for MC reference 5 
doses of 2%   level vs the non-MC evaluation dose with 3%-3mm and 2%-2mm criteria. 
Clinical case Prostate HN 
Criteria 3%-3mm 2%-2mm 3%-3mm 2%-2mm 
ROI VOI50% VOI10% VOI50% VOI10% VOI50% VOI10% VOI50% VOI10% 
Type-I Voxels (%) 1.09 0.23 5.92 1.19 0.33 0.30 2.24 1.04 
Type-II Voxels (%) 10.31 2.87 12.27 6.70 7.31 2.04 11.93 5.14 
Type-II – Type-I (%) 9.22 2.64 6.35 5.51 6.98 1.74 9.69 4.10 
 
 
3.2 Non-MC reference dose vs MC evaluation doses 
 10 
To study the effect of MC noise in the evaluation dose in γ-index tests, we treated the 
non-MC dose as the reference dose and the set of MC doses as the evaluation doses. 
Figures 5 (A) and (B) show the average γ-index values of voxels whose original γ-indices 
fall within each range as functions of the   level in the evaluation dose (         ) for prostate 
and HN cases. The average γ-index value within each group decreases dramatically with 15 
         . Figures 5 (C) and (D) show, for two different γ-index test criteria, 3%-3mm and 
2%-2mm, the passing rate within VOI50% and VOI10% as function of          . We observed 
that, the gamma passing rates saturated for 3%-3mm criterion, while the gamma passing 
rates for 2%-2mm criterion increases with the increase of          , especially for VOI50%. 
Table 2 summarizes the average percentage of Type-I or Type-II voxels within the ROIs. 20 
For the non-MC reference dose vs the MC evaluation dose of 2%   level, the percentage 
of Type-I voxels is higher than that of Type-II which means that, statistically, there are 
more voxels where the γ-index value sinks below one than voxels where the γ-index 
value rises above one. The net difference between Type-I percentage and Type–II 
percentage, is the same as the change of the gamma passing rate with the MC dose of 2% 25 
  level, shown in Figures 5 (C) and (D). 
 In Section 2.2.2, we have noticed that, when the statistical standard deviation in 
the MC evaluation dose distribution is relatively large for the original γ-index value, the 
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γ-index value will be overestimated on average due to the noise. Figures 6 (A) and (B) 
show the average γ-index value of voxels with small original γ-index values, ranging 
from 0.1 to 0.24, as functions of           for the prostate and HN cases. From Figure 6 we 
can see that when the original γ-index value is large enough, i.e. larger than 0.2, the 
average γ-index decreases with           (shown in blue and dashed lines); however, when 5 
the original γ-index value is very small, i.e. smaller than 0.14, the average γ-index 
increases with           (shown in green and dotted lines). For the in-between original γ-
index value, the average γ-index first decreases and then increases with           (shown in 
red and dashed/dotted lines). We would like to point out that voxels with this range of 
original γ-index values do not contribute to the passing rate change.  10 
  
  
Figure 5. Average γ-index and gamma passing rate as functions of   level in the evaluation dose 
for non-MC reference dose vs MC evaluation doses. (A) and (C): prostate case; (B) and (D): HN 
case. 
 
Table 2. Percentages of Type-I and Type-II voxels within VOI50% and VOI10% for the non-MC 15 
reference dose vs MC evaluation doses of 2%   level with 3%-3mm and 2%-2mm criteria. 
Clinical case Prostate HN 
Criteria 3%-3mm 2%-2mm 3%-3mm 2%-2mm 
ROI VOI50% VOI10% VOI50% VOI10% VOI50% VOI10% VOI50% VOI10% 
Type-I Voxels (%) 0.50 0.09 7.20 1.22 0.510 0.097 3.63 1.06 
Type-II Voxels (%) 0.02 0.01 0.48 0.20 0.004 0.003 0.38 0.16 
Type-I – Type-II (%) 0.48 0.08 6.72 1.02 0.506 0.094 3.25 0.90 
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Figure 6. Average γ-index as functions of   level in evaluation dose for non-MC reference dose 
vs MC evaluation doses. (A): prostate case; (B): HN case. 
 
3.3 MC reference dose vs MC evaluation dose 
 5 
To analyze the situation when both the evaluation and reference doses are generated by 
the MC method, we considered the set of MC doses as the reference doses and the other 
set of MC doses with the shifted isocenter as the evaluation doses. Figure 7 shows the 
color maps of the gamma passing rate in high dose region VOI50% under 3%-3mm 
criterion. The  -axis is the   level in the evaluation dose, while the  -axis is the   level in 10 
the reference dose. The values at origin of the two maps are the base value with zero   
level in both reference and evaluation doses. Along the  -axis, the results correspond to 
the cases for the non-MC reference dose versus MC evaluation doses, same as in Figures 
5 (C) and (D). Along the  -axis, the results correspond to the cases for MC reference 
doses versus the non-MC evaluation dose, same as in Figures 4 (C) and (D). The black 15 
lines in Figure 7 illustrate iso-value lines on which the passing rate is the same as the 
base value for MC doses of zero   level. The iso-value line splits the map into two 
regions: the upper-left region, where the MC noise level is relatively high in the reference 
dose leading to the underestimation of the gamma passing rate, and the lower-right 
region, where the MC noise level is relatively high in the evaluation dose leading to the 20 
overestimation of the gamma passing rate. The shape of iso-value line and the way that it 
splits the map are case-dependent. When both doses are the MC doses, we redefine Type-
I voxels as those with γ-index values larger than one when the   level is zero in both the 
evaluation and the reference doses and less than or equal to one when the   level is 2% in 
both doses; Type-II voxels are those with the opposite situation, i.e., γ-index values 25 
increasing from below or equal to one to above one when both   levels increase from 
zero and 2%. From Table 3, the average percentage of Type-I is higher than the 
percentage of Type-II voxels and the net contribution matches with the increased gamma 
passing rate in the right upper corner with 2%   level in both reference and evaluation 
doses. 30 
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Figure 7. The color maps of gamma passing rate within VOI50%  as functions of   level in the 
reference and evaluation doses for MC reference dose vs MC evaluation dose with 3%-3mm 
criterion. (A): prostate case; (B): HN case. 
 5 
Table 3. Percentages of Type-I and Type-II voxels within VOI50%  for the MC reference dose of 
2%   level vs the MC evaluation dose of 2%   level with 3%-3mm criterion. 
Clinical case Type-I Voxels (%) Type-II Voxels (%) Type-I – Type-II (%) 
Prostate 7.80 3.91 3.89 
HN 6.54 4.39 2.15 
 
4.  Discussion and Conclusions 
 10 
In this paper, we have first demonstrated in a simplified 1D model that, to the first order 
approximation, MC statistical fluctuation in the reference dose tends to overestimate the 
γ-index, while that in the evaluation dose tends to underestimate the γ-index when the 
original γ-index value is relatively large. This simplified model does not serve as a strict 
theoretical proof but rather as a theoretical guidance for 2D and 3D cases. To validate the 15 
theoretical conclusions, we conducted numerical experiments on two clinical cases for 
photon radiation therapy: an IMRT prostate case and a VMAT HN case. We focused on 
voxels with clinically relevant γ-index values in the absence of noise, range of 0.6 to 1.4, 
and found that when performing γ-index tests between an MC reference dose and a non-
MC evaluation dose, the average γ-index is overestimated but the change is not 20 
significant. Second, when performing γ-index tests between a non-MC reference dose 
and an MC evaluation dose, the average γ-index is underestimated and decreases with the 
increase of noise level in the evaluation dose. This is doubly confirmed by the blue 
dashed curves in the Figure 6. When the original γ-index value    is larger than 0.2, the 
average γ-index monotonically decreases with the increase of the noise level. For the 25 
green dotted curves in the Figure 6, when the    is smaller than     , the average γ-index 
increases with the noise level. For those cases with    lying in between the above two 
limits, the average γ-index first decreases when the noise level is low and then increases. 
Nonetheless, in the latter two situations, the changes of γ-index values due to the MC 
noise are not expected to considerably impact the gamma passing rates, since the small 30 
original γ-index values are much smaller than one. Hence these two situations are not 
clinically relevant. 
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 The change for the gamma passing rate within the ROI due to the MC noise is 
most relevant for the clinical applications of γ-index test. In the experiment, we defined 
two quantities, percentage of Type-I voxels and percentage of Type-II voxels and we 
found the following. 1) When performing γ-index test between an MC reference dose and 
a non-MC evaluation dose, the gamma passing rate decreases with the increase of the 5 
statistical noise level in the reference dose. 2) When performing γ-index test between a 
non-MC reference dose and an MC evaluation dose, the gamma passing rate increases 
with the increase of the noise level in the evaluation dose. In these two situations, the 
magnitude of the change of gamma passing rate when 2%   level exists in the MC dose 
equals to the difference between the percentage of Type-I and that of Type-II voxels. 3) 10 
When the reference dose and the evaluation dose are both MC doses, the gamma passing 
rate increases when the statistical noise in the evaluation dose increases. It decreases 
when the statistical noise in the reference dose increases. Considering again the 
correlation between the neighboring voxels in the MC evaluation dose, this effect on the 
γ-index is usually local in the spatial domain. However, since the gamma passing rate is a 15 
statistical overall effect from all the voxels within the ROI, the local effect will be 
smeared out in the whole ROI. 
 For the two clinical cases we have tested, the effect on the gamma passing rate is 
quite significant. Taking the 3%-3mm test criterion as an example, when there exists 2% 
MC   level in the reference dose, the gamma passing rate in VOI50% drops from 97.5% to 20 
88.3% and in VOI10% from 99.4% to 96.8% for the prostate case. For the HN case, the 
gamma passing rate in VOI50% drops from 97.7%  to 90.7% and in VOI10%  from 98.6% to 
96.9%, respectively. On the other hand, when 2% MC noise level exists in the evaluation 
dose, the resulting increase of the gamma passing rate is not significant under the 3%-
3mm criterion. This is because the passing rate is already very close to one in the absence 25 
of noise for this relatively loose criterion. However, the changes are more obvious under 
2%-2mm criterion. Especially in VOI50%, it increases from 91.9% to 98.6% for the 
prostate case and from 95.3% to 98.5% for the HN case. Based on our theoretical and 
numerical results, we conclude that great caution is needed when dealing with MC doses 
in γ-index tests. The MC statistical fluctuation effect should be considered when 30 
analyzing the γ-index test results to avoid biased conclusions. In practice, we should try 
to alleviate this problem. A straightforward approach is to simulate a large number of 
particle histories in an MC dose calculation to reduce the MC statistical uncertainty. 
Additionally, denoising the MC dose results can also be performed. 
 The conclusions based on our theoretical analysis were verified using Monte 35 
Carlo simulations with clinical photon beams. The studies for other types of clinical 
radiation beams such as electron, proton, and heavy ion beams will be performed in the 
future. 
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